The evolution of aesthetic medicine is rooted in the increasingly sophisticated mastery of Hyaluronic Acid (HA) rheology. For the modern practitioner, selecting an injectable is no longer merely a question of concentration, but of the cross-linking technology employed. This technology dictates the clinical behavior of the gel: its lifting capacity, resistance to enzymatic degradation, and tissue integration profile. This reference guide analyzes the four primary technological pillars—Vycross, Hylacross, OBT, and NAHYCO—to provide scientific clarity for clinical protocols across European practices.
Why Cross-Linking Defines Clinical Behavior
In its natural state, Hyaluronic Acid has an extremely short half-life, typically estimated at less than 48 hours. To transform this polymer into a durable medical implant, manufacturers utilize a bonding agent, usually BDDE (Butanediol Diglycidyl Ether), to create a stable, three-dimensional network.
Impact on Longevity and Texture
The absence of cross-linking results in a linear fluid that flows and degrades rapidly, a characteristic inherent to mesotherapy solutions. Conversely, controlled cross-linking transforms HA into a viscoelastic gel. The higher the cross-linking density, the more "robust" the gel becomes against endogenous hyaluronidase, though this can influence its flexibility and diffusion capacity.
Juvéderm: Striking the Balance Between Hylacross and Vycross
Allergan Aesthetics has strategically segmented its portfolio around two distinct technological approaches, each engineered to meet specific rheological requirements in clinical practice.
Hylacross Technology (The Ultra Range)
Hylacross technology is based on high-molecular-weight HA chains with a high degree of cross-linking. It produces a polydensified monophasic gel known for its exceptionally smooth consistency. From a clinical perspective, the ultra range such as Juvéderm Ultra 3 and Ultra 4 exhibit strong hydrophilic properties. They are ideal for providing immediate, robust volume in areas like the nasolabial folds, though they require careful placement in regions prone to fluid retention or edema.
Vycross Technology
Vycross technology utilizes an innovative blend of both low- and high-molecular-weight HA chains, that we find in the Juvederm Voluma, Volift, Volbella and Volux. This unique architecture optimizes cross-linking efficiency while minimizing the concentration of BDDE. The clinical advantages are significant: lower hydrophilicity—which reduces post-injection swelling—superior malleability for seamless tissue integration, and enhanced durability, with results frequently persisting beyond 18 months.
OBT (Optimal Balance Technology) : Restylane’s Dynamic Approach
Developed by Galderma, OBT technology (also known as XpresHAn Technology™) was engineered to meet the challenges of the face's mobile regions. Unlike the more rigid gels in the classic NASHA range, OBT gels are designed to be supple and extensible. They possess a high level of elastic strain, allowing them to stretch and return to their original shape without fragmentation. This characteristic facilitates natural facial expressions, where the product moves in tandem with muscular dynamics rather than resisting them. It is the technology of choice for the perioral area and lips (Restylane Kysse), where movement is as critical as volume.
NAHYCO — Why Profhilo Is Not a Filler
IBSA’s NAHYCO® technology offers a radically different paradigm: thermal cross-linking. Here, no chemical agents like BDDE are used. Through a patented thermal cycle, high and low molecular weight HA chains form Hybrid Cooperative Complexes. This structure is not intended to fill a void or project volume, but to induce bio-remodeling. Profhilo diffuses broadly through the tissue to stimulate CD44 receptors on fibroblasts, promoting the production of four types of collagen and elastin. The result is a global improvement in skin quality and a restoration of turgor without altering the patient’s facial structure.
Clinical Synthesis: Selecting Technology by Scenario
Technological choice should be guided by injection depth and the aesthetic objective. For deep structural restoration on the bone (such as the malar area), technologies offering high projection like Vycross or dense particulated gels are preferred. For areas of intense facial mimicry where discretion in both touch and movement is paramount, OBT technology is superior. Finally, for patients presenting with global skin laxity without the need for volumization, the non-chemically cross-linked approach of NAHYCO provides the most appropriate solution.
Are you a healthcare professional operating within the European Union? RM365 Netherlands supports your practice with authentic, certified medical devices. Contact us by email or whatsapp
The information below is required for social login
Sign In
Create New Account